Open Access
Issue
Parasite
Volume 23, 2016
Article Number 45
Number of page(s) 6
DOI https://doi.org/10.1051/parasite/2016056
Published online 20 October 2016
  1. Bobic B, Klun I, Vujanic M, Nikolic A, Ivovic V, Zivkovic T, Djurkovic-Djakovic O. 2009. Comparative evaluation of three commercial Toxoplasma-specific IgG antibody avidity tests and significance in different clinical settings. Journal of Medical Microbiology, 58, 358–364. [CrossRef] [PubMed] [Google Scholar]
  2. Calderaro A, Piccolo G, Peruzzi S, Gorrini C, Chezzi C, Dettori G. 2008. Evaluation of Toxoplasma gondii immunoglobulin G (IgG) and IgM assays incorporating the newVidia analyzer system. Clinical and Vaccine Immunology, 15, 1076–1079. [CrossRef] [Google Scholar]
  3. Curdt I, Praast G, Sickinger E, Schultess J, Herold I, Braun HB, Bernhardt S, Maine GT, Smith DD, Hsu S, Christ HM, Pucci D, Hausmann M, Herzogenrath J. 2009. Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays. Journal of Clinical Microbiology, 47, 603–613. [CrossRef] [PubMed] [Google Scholar]
  4. Dai L-Y, Jin W-J. 2005. Interobserver and intraobserver reliability in the load sharing classification of the assessment of thoracolumbar burst fractures. Spine, 30, 354–358. [Google Scholar]
  5. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. 1999. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet, 353, 1829–1833. [Google Scholar]
  6. Flori P, Bellete B, Crampe C, Maudry A, Patural H, Chauleur C, Hafid J, Raberin H, Tran Manh Sung R. 2008. A technique for dating toxoplasmosis in pregnancy and comparison with the Vidas anti-toxoplasma IgG avidity test. Clinical Microbiology and Infection, 14, 242–249. [CrossRef] [Google Scholar]
  7. Flori P, Tardy L, Patural H, Bellete B, Varlet M-N, Hafid J, Raberin H, Sung RTM. 2004. Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women. Clinical and Diagnostic Laboratory Immunology, 11, 669–674. [PubMed] [Google Scholar]
  8. Fricker-Hidalgo H, Saddoux C, Suchel-Jambon AS, Romand S, Foussadier A, Pelloux H, Thulliez P. 2006. New Vidas assay for Toxoplasma-specific IgG avidity: evaluation on 603 sera. Diagnostic Microbiology and Infectious Disease, 56, 167–172. [CrossRef] [PubMed] [Google Scholar]
  9. Garry DJ, Elimian A, Wiencek V, Baker DA. 2005. Commercial laboratory IgM testing for Toxoplasma gondii in pregnancy: a 20-year experience. Infectious Diseases in Obstetrics and Gynecology, 13, 151–153. [CrossRef] [PubMed] [Google Scholar]
  10. Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M. 2004. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiology and Infection, 132, 541–548. [CrossRef] [PubMed] [Google Scholar]
  11. Lefevre-Pettazzoni M, Le Cam S, Wallon M, Peyron F. 2006. Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women. European Journal of Clinical Microbiology & Infectious Diseases, 25, 687–693. [CrossRef] [Google Scholar]
  12. Marty P, Le Fichoux Y. 1992. Couplage des 2 tests toxo G EIA*/IMX toxo IgG* pour la datation d’une contamination toxoplasmique chez la femme enceinte. Bulletin de la Société Française de Parasitologie, 10, 177–182. [Google Scholar]
  13. Montoya JG, Liesenfeld O, Kinney S, Press C, Remington JS. 2002. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. Journal of Clinical Microbiology, 40, 2504–2508. [CrossRef] [PubMed] [Google Scholar]
  14. Montoya JG, Remington JS. 2008. Management of Toxoplasma gondii infection during pregnancy. Clinical Infectious Disease, 47, 554–566. [CrossRef] [Google Scholar]
  15. Murat J-B, Dard C, Fricker Hidalgo H, Dardé M-L, Brenier-Pinchart M-P, Pelloux H. 2013. Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns. Clinical and Vaccine Immunology, 20, 1203–1212. [CrossRef] [Google Scholar]
  16. Nascimento FS, Suzuki LA, Rossi CL. 2008. Assessment of the value of detecting specific IgA antibodies for the diagnosis of a recently acquired primary Toxoplasma infection. Prenatal Diagnosis, 28, 749–752. [CrossRef] [PubMed] [Google Scholar]
  17. Press C, Montoya JG, Remington JS. 2005. Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults. Journal of Clinical Microbiology, 43, 3481–3483. [CrossRef] [PubMed] [Google Scholar]
  18. Ribeiro AC, Mutis MS, Fernandes O. 2008. Association of the presence of residual anti-Toxoplasma gondii IgM in pregnant women and their respective family groups in Miracema, Northwest Rio de Janeiro, Brazil. Memórias do Instituto Oswaldo Cruz, 103, 591–594. [CrossRef] [Google Scholar]
  19. Sickinger E, Gay-Andrieu F, Jonas G, Schultess J, Stieler M, Smith D, Hausmann M, Stricker R, Stricker R, Dhein J, Braun H-B. 2008. Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays. Diagnostic Microbiology and Infectious Disease, 62, 235–244. [CrossRef] [PubMed] [Google Scholar]
  20. Thulliez P, Daffos F, Forestier F. 1992. Diagnosis of Toxoplasma infection in the pregnant woman and the unborn child: current problems. Scandinavian Journal of Infectious Diseases Suppl, 84, 18–22. [Google Scholar]
  21. Vendrell JP, Pratlong F, Decoster A, Boulot P, Conge AM, Darcy F, Segondy M, Huguet MF, Serre A. 1992. Secretion of Toxoplasma gondii-specific antibody in vitro by peripheral blood mononuclear cells as a new marker of acute toxoplasmosis. Clinical & Experimental Immunology, 89, 126–130. [CrossRef] [Google Scholar]
  22. Villard O, Breit L, Cimon B, Franck J, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E, French National Reference Center for Toxoplasmosis Network. 2013. Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies. Clinical and Vaccine Immunology, 20, 197–204. [CrossRef] [Google Scholar]
  23. Vlaspolder F, Singer P, Smit A, Diepersloot RJ. 2001. Comparison of immulite with vidas for detection of infection in a low-prevalence population of pregnant women in The Netherlands. Clinical and Diagnostic Laboratory Immunology, 8, 552–555. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.